These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3277508)

  • 21. Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin.
    Edwards R; Kanematsu M; Greenwood D
    J Antimicrob Chemother; 1988 Dec; 22(6):885-90. PubMed ID: 3243736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of norfloxacin in children].
    Ihara T; Kawaguchi H; Ito M; Kamiya H; Sakurai M
    Jpn J Antibiot; 1990 May; 43(5):852-9. PubMed ID: 2391756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current antimicrobial agent series III: Norfloxacin].
    Ueda Y; Matsumoto F
    Jpn J Antibiot; 1988 Jul; 41(7):782-96. PubMed ID: 3050183
    [No Abstract]   [Full Text] [Related]  

  • 24. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA; Todd PA; Peters DH
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laboratory and clinical studies on norfloxacin in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
    Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effect of norfloxacin in pediatric field].
    Ishikawa J; Matsuura T; Nagai H; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1990 May; 43(5):877-83. PubMed ID: 2391759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norfloxacin in the therapy of uncomplicated gonorrhea.
    Romanowski B; Wood H; Draker J; Tsianco MC
    Antimicrob Agents Chemother; 1986 Sep; 30(3):514-5. PubMed ID: 3096197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
    Paton JH; Reeves DS
    Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial of norfloxacin in the treatment of uncomplicated gonococcal urethritis: preliminary report.
    Cristiano P
    Drugs Exp Clin Res; 1989; 15(1):33-5. PubMed ID: 2501077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.
    Tanaka M; Otsuki M; Nishino T; Kobayashi I; Matsumoto T; Kumazawa J
    Genitourin Med; 1996 Aug; 72(4):295-7. PubMed ID: 8976839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P; Honderlick P
    Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.
    Cox CE; McCabe RE; Grad C
    Am J Med; 1987 Jun; 82(6B):59-64. PubMed ID: 3300312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of urinary tract infection with norfloxacin. Analysis of cost.
    Ramirez-Ronda C; Colon M; Saavedra S; Sabbaj J; Corrado ML
    Am J Med; 1987 Jun; 82(6B):75-8. PubMed ID: 3300315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O; Boratyńska M; Mróz E; Starek J
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):154-7. PubMed ID: 8090671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA; Noone P
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Laboratory and clinical studies on norfloxacin in pediatrics].
    Sato Y; Iwata S; Akita H; Sunakawa K
    Jpn J Antibiot; 1990 May; 43(5):826-36. PubMed ID: 2391753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symposium on antimicrobial agents. The quinolones.
    Walker RC; Wright AJ
    Mayo Clin Proc; 1987 Nov; 62(11):1007-12. PubMed ID: 3312850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.